Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.26 - $0.48 $0 - $0
1 Added 0.49%
207 $0
Q1 2022

May 16, 2022

SELL
$0.89 - $1.26 $16 - $22
-18 Reduced 8.04%
206 $0
Q4 2021

Feb 08, 2022

BUY
$1.02 - $1.93 $18 - $34
18 Added 8.74%
224 $0
Q3 2021

Nov 15, 2021

SELL
$1.87 - $2.57 $130 - $179
-70 Reduced 25.36%
206 $0
Q2 2021

Sep 13, 2021

BUY
$2.24 - $2.9 $618 - $800
276 New
276 $1,000

Others Institutions Holding TTNP

# of Institutions
1
Shares Held
23
Call Options Held
0
Put Options Held
0

About TITAN PHARMACEUTICALS INC


  • Ticker TTNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,629,200
  • Market Cap $49.4M
  • Description
  • Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...
More about TTNP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.